These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37452459)
21. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Koen Talsma A; Shapiro J; Looman CW; van Hagen P; Steyerberg EW; van der Gaast A; van Berge Henegouwen MI; Wijnhoven BP; van Lanschot JJ; ; Hulshof MC; van Laarhoven HW; Nieuwenhuijzen GA; Hospers GA; Bonenkamp JJ; Cuesta MA; Blaisse RJ; Busch OR; ten Kate FJ; Creemers GJ; Punt CJ; Plukker JT; Verheul HM; van Dekken H; van der Sangen MJ; Rozema T; Biermann K; Beukema JC; Piet AH; van Rij CM; Reinders JG; Tilanus HW Ann Surg; 2014 Nov; 260(5):786-92; discussion 792-3. PubMed ID: 25379850 [TBL] [Abstract][Full Text] [Related]
22. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma. Chen HS; Lin CH; Wu SC; Wang BY Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899 [TBL] [Abstract][Full Text] [Related]
23. Supraclavicular lymph node metastasis should not be defined as regional lymph node metastasis in cervical and upper thoracic esophageal squamous cell carcinoma. Zeng H; Zhu M; Sun Y; Deng L; Fu W; Li S; Xiang Y; Zhang W Oncol Lett; 2024 Oct; 28(4):462. PubMed ID: 39119233 [TBL] [Abstract][Full Text] [Related]
24. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
25. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Klevebro F; Alexandersson von Döbeln G; Wang N; Johnsen G; Jacobsen AB; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M Ann Oncol; 2016 Apr; 27(4):660-7. PubMed ID: 26782957 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma. Hsu PK; Chen HS; Liu CC; Wu SC Ann Surg Oncol; 2019 Feb; 26(2):506-513. PubMed ID: 30430325 [TBL] [Abstract][Full Text] [Related]
27. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer. Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762 [TBL] [Abstract][Full Text] [Related]
28. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Noordman BJ; Spaander MCW; Valkema R; Wijnhoven BPL; van Berge Henegouwen MI; Shapiro J; Biermann K; van der Gaast A; van Hillegersberg R; Hulshof MCCM; Krishnadath KK; Lagarde SM; Nieuwenhuijzen GAP; Oostenbrug LE; Siersema PD; Schoon EJ; Sosef MN; Steyerberg EW; van Lanschot JJB; Lancet Oncol; 2018 Jul; 19(7):965-974. PubMed ID: 29861116 [TBL] [Abstract][Full Text] [Related]
29. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010 [TBL] [Abstract][Full Text] [Related]
30. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467 [TBL] [Abstract][Full Text] [Related]
31. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100 [TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy. Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875 [TBL] [Abstract][Full Text] [Related]
33. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study. van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL; Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163 [TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus. Münch S; Pigorsch SU; Devečka M; Dapper H; Feith M; Friess H; Weichert W; Jesinghaus M; Braren R; Combs SE; Habermehl D Radiat Oncol; 2019 Apr; 14(1):66. PubMed ID: 30992022 [TBL] [Abstract][Full Text] [Related]
35. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy. Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176 [TBL] [Abstract][Full Text] [Related]
36. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309 [TBL] [Abstract][Full Text] [Related]
37. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362 [TBL] [Abstract][Full Text] [Related]
38. Real-world evaluation of multimodal treatment practice in older oesophageal cancer patients. Shen T; Zhang Y; Cao Y; Zhang J; Li H Eur J Cardiothorac Surg; 2024 Oct; 66(4):. PubMed ID: 39298505 [TBL] [Abstract][Full Text] [Related]
39. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. Depypere L; De Hertogh G; Moons J; Provoost AL; Lerut T; Sagaert X; Coosemans W; Van Veer H; Nafteux P Ann Thorac Surg; 2021 Dec; 112(6):1847-1854. PubMed ID: 33352178 [TBL] [Abstract][Full Text] [Related]
40. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis. Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]